Spectrum of SPG4 mutations in autosomal dominant spastic paraplegia

被引:239
作者
Fonknechten, N
Mavel, D
Byrne, P
Davoine, CS
Cruaud, C
Boentsch, D
Samson, D
Coutinho, P
Hutchinson, M
McMonagle, P
Burgunder, JM
Tartaglione, A
Heinzlef, O
Feki, I
Deufel, T
Parfrey, N
Brice, A
Fontaine, B
Prud'homme, JF
Weissenbach, J
Dürr, A
Hazan, J
机构
[1] Genoscope, F-91000 Evry, France
[2] Univ Coll Dublin, Dept Pathol, Dublin 2, Ireland
[3] Fac Med Pitie Salpetriere, INSERM CJF9711, Paris, France
[4] Klinikum Univ Jena, Inst Klin Chem & Lab Diagnost, Jena, Germany
[5] Dept Med, Serv Neurol, Santa Maria De Feira, Portugal
[6] St Vincents Univ Hosp, Dept Neurol, Dublin, Ireland
[7] Univ Spital Bern, Neurol Klin & Poliklin, Bern, Switzerland
[8] Hosp Civile S Andrea, Div Neurol, La Spezia, Italy
[9] Hop Tenon, Serv Neurol, F-75970 Paris, France
[10] Grp Hosp Pitie Salpetriere, Consultat Genet Med, F-75634 Paris, France
[11] Grp Hosp Pitie Salpetriere, Federat Neurol, F-75634 Paris, France
[12] Grp Hosp Pitie Salpetriere, INSERM, U289, F-75634 Paris, France
[13] Genethon, Evry, France
关键词
D O I
10.1093/hmg/9.4.637
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Autosomal dominant hereditary spastic paraplegia (AD-HSP) is a group of genetically heterogeneous neurodegenerative disorders characterized by progressive spasticity of the lower limbs. Five AD-HSP loci have been mapped to chromosomes 14q, 2p, 15q, 8q and 12q, The SPG4 locus at 2p21-p22 has been shown to account for similar to 40% of all AD-HSP families. SPG4 encoding spastin, a putative nuclear AAA protein, has recently been identified. Here, sequence analysis of the 17 exons of SPG4 in 87 unrelated AD-HSP patients has resulted in the detection of 34 novel mutations. These SPG4 mutations are scattered along the coding region of the gene and include all types of DNA modification including missense (28%), nonsense (15%) and splice site point (26.5%) mutations as well as deletions (23%) and insertions (7.5%), The clinical analysis of the 238 mutation carriers revealed a high proportion of both asymptomatic carriers (14/238) and patients unaware of symptoms (45/238), and permitted the redefinition of this frequent form of AD-HSP.
引用
收藏
页码:637 / 644
页数:8
相关论文
共 31 条
[1]
Beyer A, 1997, PROTEIN SCI, V6, P2043
[2]
Linkage of AD HSP and cognitive impairment to chromosome 2p: haplotype and phenotype analysis indicates variable expression and low or delayed penetrance [J].
Byrne, PC ;
Webb, S ;
McSweeney, F ;
Burke, T ;
Hutchinson, M ;
Parfrey, NA .
EUROPEAN JOURNAL OF HUMAN GENETICS, 1998, 6 (03) :275-282
[3]
Characterization of single-nucleotide polymorphisms in coding regions of human genes [J].
Cargill, M ;
Altshuler, D ;
Ireland, J ;
Sklar, P ;
Ardlie, K ;
Patil, N ;
Lane, CR ;
Lim, EP ;
Kalyanaraman, N ;
Nemesh, J ;
Ziaugra, L ;
Friedland, L ;
Rolfe, A ;
Warrington, J ;
Lipshutz, R ;
Daley, GQ ;
Lander, ES .
NATURE GENETICS, 1999, 22 (03) :231-238
[4]
Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease [J].
Casari, G ;
De Fusco, M ;
Ciarmatori, S ;
Zeviani, M ;
Mora, M ;
Fernandez, P ;
De Michele, G ;
Filla, A ;
Cocozza, S ;
Marconi, R ;
Dürr, A ;
Fontaine, B ;
Ballabio, A .
CELL, 1998, 93 (06) :973-983
[5]
A 200-AMINO ACID ATPASE MODULE IN SEARCH OF A BASIC FUNCTION [J].
CONFALONIERI, F ;
DUGUET, M .
BIOESSAYS, 1995, 17 (07) :639-650
[6]
COOPER DN, 1993, HUMAN GENE MUTATION, P239
[7]
THE PHENOTYPE OF PURE AUTOSOMAL-DOMINANT SPASTIC PARAPLEGIA [J].
DURR, A ;
BRICE, A ;
SERDARU, M ;
RANCUREL, G ;
DEROUESNE, C ;
LYONCAEN, O ;
AGID, Y ;
FONTAINE, B .
NEUROLOGY, 1994, 44 (07) :1274-1277
[8]
Phenotype of autosomal dominant spastic paraplegia linked to chromosome 2 [J].
Durr, A ;
Davoine, CS ;
Paternotte, C ;
vonFellenberg, J ;
Cogilnicean, S ;
Coutinho, P ;
Lamy, C ;
Bourgeois, S ;
Prudhomme, JF ;
Penet, C ;
Mas, JL ;
Burgunder, JM ;
Hazan, J ;
Weissenbach, J ;
Brice, A ;
Fontaine, B .
BRAIN, 1996, 119 :1487-1496
[9]
FINK JK, 1995, AM J HUM GENET, V56, P188
[10]
Hereditary spastic paraplegia: Advances in genetic research [J].
Fink, JK ;
HeimanPatterson, T ;
Bird, T ;
Cambi, F ;
Dube, MP ;
Figlewicz, DA ;
Fink, JK ;
Haines, JL ;
HeimanPatterson, T ;
Hentati, A ;
PericakVance, MA ;
Raskind, W ;
Rouleau, GA ;
Siddique, T .
NEUROLOGY, 1996, 46 (06) :1507-1514